Literature DB >> 2302828

Monocyte disorder causing cellular immunodeficiency: a family study.

J Prieto1, M L Subirá, A Castilla, M P Civeira, M Serrano.   

Abstract

We report a familial type of monocyte dysfunction not recognized previously. This disorder was observed in a young adult man with a long clinical history of recurrent, self-limited episodes of cryptogenic fever accompanied by digestive and respiratory symptoms and repeated oral and skin infections. Lectin-induced lymphocyte transformation was reduced and skin tests revealed anergy to tuberculin and candidin. Monocytes from this patient exhibited markedly diminished expression of cytoskeletal vimentin intermediate filaments, HLA-DR antigens and immunological receptors for IgG Fc and C3b. These abnormal monocytes demonstrated impaired phagocytosis and reduced accessory cell function on PHA-mediated lymphocyte activation. Release of soluble lymphocyte-activating factors by these cells was found to be defective. Lymphocytes from the patient responded appropriately to lectin in the presence of normal monocytes. Two family members of the proband presented similar monocyte defects although they only manifested minor clinical symptoms. This syndrome underlines the interest of testing monocyte markers and function in subjects with clinical manifestations of immunodeficiency.

Entities:  

Mesh:

Year:  1990        PMID: 2302828      PMCID: PMC1534715          DOI: 10.1111/j.1365-2249.1990.tb05118.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Human vascular smooth muscle cells. Target for and source of tumor necrosis factor.

Authors:  S J Warner; P Libby
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

2.  Cytoskeletal organization and functional changes in monocytes from patients with chronic hepatitis B: relationship with viral replication.

Authors:  J Prieto; A Castilla; M L Subirá; M Serrano; S Morte; M P Civeira
Journal:  Hepatology       Date:  1989-05       Impact factor: 17.425

3.  Opioid peptides modulate the organization of vimentin filaments, phagocytic activity, and expression of surface molecules in monocytes.

Authors:  J Prieto; M L Subirá; A Castilla; J L Arroyo; M Serrano
Journal:  Scand J Immunol       Date:  1989-04       Impact factor: 3.487

Review 4.  Current concepts: immunology. Monocytes and macrophages.

Authors:  R B Johnston
Journal:  N Engl J Med       Date:  1988-03-24       Impact factor: 91.245

Review 5.  Mechanism of T cell activation: role and functional relationship of HLA-DR antigens and interleukins.

Authors:  R Palacios
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

6.  Functional significance of the regulation of macrophage Ia expression.

Authors:  D I Beller
Journal:  Eur J Immunol       Date:  1984-02       Impact factor: 5.532

7.  Nature of the immunogenic moiety recognized by the human T cell proliferating in response to tetanus toxoid antigen.

Authors:  M D Broff; M E Jonsen; R S Geha
Journal:  Eur J Immunol       Date:  1981-05       Impact factor: 5.532

8.  Role of interleukin 1 in antigen-specific T cell proliferation.

Authors:  E Chu; L J Rosenwasser; C A Dinarello; M Lareau; R S Geha
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

9.  Human monocyte heterogeneity: interleukin 1 and prostaglandin E2 production by separate subsets.

Authors:  N Khansari; Y K Chou; H H Fudenberg
Journal:  Eur J Immunol       Date:  1985-01       Impact factor: 5.532

10.  Naloxone-reversible monocyte dysfunction in patients with chronic fatigue syndrome.

Authors:  J Prieto; M L Subirá; A Castilla; M Serrano
Journal:  Scand J Immunol       Date:  1989-07       Impact factor: 3.487

View more
  1 in total

1.  Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro.

Authors:  Simona Bancos; David L Stevens; Katherine M Tyner
Journal:  Int J Nanomedicine       Date:  2014-12-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.